When Intrusive Thoughts and Compulsions Take Over
Obsessive-compulsive disorder affects millions of adults in the United States, and some patients continue to experience significant symptoms despite first-line treatment. The experience of treatment-resistant OCD is a particular kind of suffering: a person may understand intellectually that intrusive thoughts are irrational, yet compulsions can feel impossible to resist. The mental exhaustion of fighting them hour after hour can become its own disability.
At Albany Ketamine Infusions, we are seeing increasing interest in ketamine as a potential option for patients with OCD who have not found enough relief through conventional approaches.
Understanding OCD Beyond the Stereotype
OCD is often mischaracterized as a preference for tidiness or a quirk of personality. The clinical reality is far more severe. OCD is characterized by intrusive, unwanted thoughts or images—obsessions—and repetitive behaviors or mental acts performed to reduce the distress those thoughts create—compulsions.
The cycle can be relentless: an intrusive thought arrives, anxiety spikes, a compulsion is performed, anxiety briefly drops, and the thought returns. Over time, compulsions can expand, intrusive thoughts can intensify, and daily life can become increasingly restricted.
For a closer look at how OCD can present, read our guide to the different types of OCD.
Why Conventional OCD Treatment Does Not Work for Everyone
Research points to dysregulation in brain circuits involved in habit formation, threat detection, and repetitive behavior. In OCD, these systems may become difficult to interrupt even when a person recognizes that a thought or behavior is excessive.
SSRIs, clomipramine, and cognitive behavioral therapy with exposure and response prevention, or ERP, remain important first-line treatments for OCD. They can be effective, but they do not work the same way for every patient, and medication response can take several weeks to assess.
For patients who have tried multiple approaches without enough improvement, it can be difficult to consider another option. We take that treatment history seriously and approach every consultation with care, honesty, and individualized attention.
What Current Research Says About Ketamine and OCD
Ketamine’s proposed role in OCD is different from that of serotonin-targeting medications. As an NMDA receptor antagonist, ketamine affects glutamate signaling, a system researchers continue to study in relation to OCD.
Small clinical trials and case reports have described rapid reductions in obsessive symptoms for some patients following ketamine administration. A small randomized controlled study found rapid reductions in obsessions in some participants, with effects lasting at least one week for some people. However, research remains limited, and larger controlled trials are needed to better understand response rates, durability, ideal treatment protocols, and long-term outcomes.
For that reason, we do not present ketamine as a cure or a universal answer. We consider it as one possible option for patients whose OCD has remained difficult to manage despite prior care.
Our Approach to OCD Treatment
At Albany Ketamine Infusions, the consultation process for OCD patients begins with a detailed clinical intake. We review prior treatments, symptom severity, medical history, and coexisting conditions that may affect care planning.
OCD can occur alongside depression, anxiety disorders, and ADHD, so we consider the full clinical picture rather than treating one diagnosis in isolation. For appropriate candidates, IV ketamine treatment for OCD is administered in our clinic under the direct supervision of Dr. Philip Hansen.
Sessions take place in private treatment rooms, and vital signs are monitored throughout the infusion. We also consider environmental triggers and sensory sensitivities that may affect a patient’s comfort during treatment.
Ketamine-Assisted Psychotherapy and OCD
For patients who may benefit from pairing ketamine treatment with structured psychological work, we offer ketamine-assisted psychotherapy.
KAP does not replace ERP or other established OCD treatments. Instead, it may provide a structured setting for therapeutic work, reflection, and integration when clinically appropriate. Integration sessions can give patients space to process their experience and discuss how it may relate to intrusive thoughts, avoidance, compulsions, and treatment goals.
Our recent overview of ketamine-assisted psychotherapy in Albany explains more about how this coordinated model works. Discuss with your provider whether KAP is an appropriate component of your treatment plan.
When Previous Treatments Have Been Disappointing
Many OCD patients arrive after a long history of treatment. They may have tried several SSRIs, clomipramine, intensive ERP programs, and years of weekly therapy. That history can create understandable skepticism and reluctance to try something new.
We do not promise a cure, and we are honest that results vary by individual. What we can offer is a careful assessment, a thorough explanation of what the evidence does and does not show, and a commitment to walking through the process with you regardless of outcome.
For loved ones trying to help someone with OCD, it can also be useful to understand the difference between support and accommodation. Our article on how to stop enabling OCD behavior explores this topic in more detail.
Access and Treatment Planning
Patients in Albany and surrounding communities may face practical barriers to in-person care, including travel, work obligations, and symptom-related difficulty leaving home. For eligible patients, our at-home ketamine program may be another option to discuss.
At-home ketamine is not automatically appropriate for every patient with OCD. Eligibility requires careful clinical screening and an individualized evaluation of the home setting, support structure, treatment history, and broader clinical needs.
For patients considering in-office care, our guide to starting treatment at a ketamine clinic outlines what the consultation and treatment-planning process may involve.
Frequently Asked Questions
Is ketamine treatment for OCD FDA-approved?
No. Ketamine treatment for OCD is off-label, meaning it has not received specific FDA approval for this indication. Off-label prescribing is an established medical practice, but it should involve a careful discussion of the evidence, possible risks, alternatives, and individual circumstances.
How quickly might ketamine reduce OCD symptoms?
Some research participants have reported reductions in obsessive symptoms quickly after treatment. However, response and duration vary significantly among individuals, and we cannot predict in advance whether a patient will respond or how long benefits may last.
Will ketamine work for my OCD if SSRIs have not helped?
A lack of response to SSRIs does not determine whether someone will respond to ketamine or whether ketamine is appropriate for their situation. No treatment works for every patient. We discuss your history, current symptoms, and treatment goals thoroughly during consultation.
What is the difference between ketamine for OCD and ERP therapy?
ERP remains an important evidence-based behavioral treatment for OCD and is not replaced by ketamine. Ketamine and psychotherapy may be considered as part of a broader, individualized plan for appropriate patients, but treatment decisions should be made with qualified providers who understand your full clinical history.
How do I get started with ketamine for OCD in Albany?
The first step is scheduling a consultation with our team. We review your clinical history, prior treatments, and current symptoms to determine whether you are an appropriate candidate and to discuss a personalized treatment plan.
Key Takeaways
- OCD involves intrusive thoughts and compulsive behaviors that can significantly interfere with daily life.
- SSRIs, clomipramine, and ERP remain important treatment options, but some patients continue to experience significant symptoms.
- Early research suggests ketamine may reduce obsessive symptoms rapidly for some patients, though the evidence base remains limited and evolving.
- Ketamine-assisted psychotherapy may be considered alongside structured psychological work when clinically appropriate.
- Results vary by individual. Discuss with your provider whether ketamine may be appropriate for your OCD and treatment history.
Conclusion
OCD can be one of the most persistent and underappreciated mental health conditions. If intrusive thoughts have not yielded to conventional treatments, we want you to know that the conversation does not have to end there.
Our team at Albany Ketamine Infusions is here to assess your history with care, explain your options honestly, and walk alongside you toward a treatment approach that may offer a new direction. Schedule a consultation to speak with our team.
About Dr. Philip Hansen
Dr. Philip Hansen is a board-certified anesthesiologist who trained at Albany Medical Center. He established Albany Ketamine Infusions in partnership with Dr. Brooks, building on his training at NY Ketamine Infusions. Dr. Hansen graduated from the University of Kansas School of Medicine and holds membership in the American Society of Anesthesiologists, the American Medical Association, and the New York State Society of Anesthesiologists. He provides medical oversight for both in-office IV ketamine infusions and at-home telehealth ketamine programs for patients across New York, New Jersey, Florida, and Texas.
Works Cited
Bandeira, I. D., Lins-Silva, D. H., Cavenaghi, V. B., Dorea-Bandeira, I., Faria-Guimarães, D., Barouh, J. L., Jesus-Nunes, A. P., Beanes, G., Souza, L. S., Leal, G. C., Sanacora, G., Miguel, E. C., Sampaio, A. S., & Quarantini, L. C. (2022). Ketamine in the treatment of obsessive-compulsive disorder: A systematic review. Harvard Review of Psychiatry, 30(2), 135–145.
International OCD Foundation. (n.d.). What is OCD?
National Institute of Mental Health. (n.d.). Obsessive-compulsive disorder: When unwanted thoughts or repetitive behaviors take over
Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M., Vermes, D., Flood, P., & Simpson, H. B. (2013). Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: Proof-of-concept. Neuropsychopharmacology, 38(12), 2475–2483.
Rodriguez, C. I., Wheaton, M., Zwerling, J., Steinman, S. A., Sonnenfeld, D., Galfalvy, H., & Simpson, H. B. (2016). Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? An open-label trial. Journal of Clinical Psychiatry, 77(3), 408–409.
Medical Disclaimer
The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Results may vary. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether this treatment is appropriate for you.